Small Cap Biotech
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Trend Stats
1-Month Return
+3.52%
3-Month Return
+6.55%
12-Month Return
+62.12%
Volatility Score
2.4
RSI
54.8
ST Trend
Up
LT Trend
Up
Short-Term Trend
Up
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Small Cap Biotech
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | $365B | +9.62% | -3.33% | +0.50% | 2.7 | Down | Down |
| AMGN | Amgen | $178B | +19.26% | -10.95% | -6.92% | 2.6 | Down | Neutral |
| GILD | Gilead Sciences | $163B | +32.50% | -8.74% | -5.02% | 2.3 | Down | Up |
| VRTX | Vertex Pharma | $108B | -14.06% | -8.64% | -2.02% | 2.2 | Down | Down |
| REGN | Regeneron Pharma | $74B | +18.14% | -8.39% | -6.91% | 2.9 | Down | Up |
| ALNY | Alnylam Pharma | $40B | +8.91% | -15.35% | -6.56% | 4.3 | Down | Down |
| RVMD | REVOLUTION MEDIC | $30B | +271.65% | +53.25% | +49.21% | 5.8 | Up | Up |
| NTRA | Natera | $30B | +34.43% | +2.89% | +1.72% | 4.9 | Up | Up |
| INSM | Insmed | $29B | +92.90% | -8.15% | -13.80% | 3.8 | Down | Down |
| BIIB | Biogen | $28B | +53.70% | +0.95% | +5.57% | 3.1 | Neutral | Up |
| UTHR | United Therapeut | $24B | +94.58% | +20.44% | +2.91% | 2.4 | Up | Up |
| ROIV | ROIVANT SCIENCES | $20B | +145.12% | +30.99% | +0.11% | 3.3 | Neutral | Up |
| INCY | Incyte | $19B | +56.40% | -5.32% | +1.26% | 3.0 | Neutral | Up |
| MRNA | MODERNA | $18B | +69.90% | +10.59% | -3.86% | 5.7 | Down | Up |
| BBIO | BRIDGEBIO PHARMA | $13B | +80.51% | -8.25% | -5.69% | 5.1 | Down | Up |
| NBIX | Neurocrine Biosc | $13B | +22.16% | -2.75% | +1.88% | 2.9 | Neutral | Down |
| SMMT | SUMMIT THERAP | $13B | -39.40% | +17.75% | -12.38% | 10.5 | Down | Down |
| IONS | Ionis Pharmaceut | $12B | +124.25% | -11.22% | +0.88% | 3.1 | Neutral | Up |
| MDGL | Madrigal Pharmct | $12B | +69.29% | +8.37% | -5.16% | 3.3 | Up | Up |
| EXEL | Exelixis | $11B | +10.87% | +3.56% | +0.66% | 2.9 | Neutral | Up |
| ARWR | Arrowhead Phrmct | $10B | +446.42% | +12.24% | +25.17% | 4.2 | Up | Up |
| BMRN | Biomarin Pharm | $10B | -10.63% | -3.75% | -0.07% | 2.5 | Down | Down |
| PRAX | PRAXIS PRECIS | $9B | +766.56% | +11.30% | +8.77% | 5.5 | Up | Up |
| PCVX | VAXCYTE | $8.2B | +70.62% | +5.81% | +0.19% | 3.7 | Down | Up |
| CYTK | Cytokinetics | $7.9B | +80.12% | +3.98% | -1.02% | 3.7 | Up | Up |
| KRYS | KRYSTAL BIOTECH | $7.8B | +76.81% | +6.62% | +9.96% | 3.6 | Up | Up |
| NUVL | NUVALENT-A | $7.8B | +36.05% | -2.26% | -2.67% | 3.5 | Neutral | Up |
| HALO | Halozyme Therape | $7.6B | +6.52% | -17.14% | +0.12% | 3.0 | Down | Down |
| IBRX | IMMUNITYBIO | $7.4B | +253.81% | +26.36% | +1.78% | 6.9 | Down | Up |
| ACLX | ARCELLX | $6.7B | +78.26% | +67.96% | +0.44% | 0.1 | Up | Up |
| KYMR | KYMERA THERAP | $6.6B | +148.93% | +7.58% | -2.12% | 4.3 | Down | Up |
| PTGX | Protagonist Ther | $6.3B | +124.75% | +19.47% | -4.10% | 3.9 | Neutral | Up |
| COGT | COGENT BIOSCIS | $6.3B | +559.43% | -0.33% | +4.32% | 3.6 | Neutral | Up |
| APGE | APOGEE THERAP | $6.1B | +112.11% | +28.78% | -0.94% | 4.2 | Up | Up |
| CELC | CELCUITY | $6.1B | +1236.22% | +34.75% | +28.72% | 5.3 | Up | Up |
| SYRE | Spyre Therap | $6B | +390.63% | +115.56% | +45.29% | 7.0 | Up | Up |
| MIRM | MIRUM REG S-AI | $5.9B | +139.61% | +1.76% | +12.34% | 4.0 | Up | Up |
| CGON | CG ONCOLOGY | $5.8B | +140.24% | +30.24% | +0.33% | 4.4 | Up | Up |
| RYTM | RHYTHM PHARM | $5.6B | +32.87% | -20.74% | -0.82% | 4.1 | Down | Down |
| ALKS | Alkermes | $5.5B | +8.82% | +0.12% | -1.92% | 3.1 | Up | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |